Crescent Biopharma Grants Stock Options to New Employees Under Inducement Plan
I'm PortAI, I can summarize articles.
Crescent Biopharma Inc. has approved stock options for five non-executive employees under its 2025 Employment Inducement Incentive Award Plan. The grant includes 117,339 ordinary shares at an exercise price of $10.15 per share, matching the closing price on January 29, 2026. The options have a 10-year term and will vest over four years, with one-fourth vesting on the first anniversary of each employee’s start date and the remainder vesting monthly thereafter.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments